148 related articles for article (PubMed ID: 20690795)
21. Frequent altered expression of fragile histidine triad protein in human colorectal adenomas.
Morikawa H; Nakagawa Y; Hashimoto K; Niki M; Egashira Y; Hirata I; Katsu K; Akao Y
Biochem Biophys Res Commun; 2000 Nov; 278(1):205-10. PubMed ID: 11071873
[TBL] [Abstract][Full Text] [Related]
22. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
23. Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.
Wang JX; Zhang YG; Zhao LS
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):273-7. PubMed ID: 19502167
[TBL] [Abstract][Full Text] [Related]
24. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.
Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K
Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174
[TBL] [Abstract][Full Text] [Related]
25. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
[TBL] [Abstract][Full Text] [Related]
26. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
27. [Influence of folate on fragile histidine triad gene expression, cell proliferation and apoptosis in cervical cancer cell lines].
Gao C; Kang H; Bai L; Ding L; Xu J; Wu T; Bai L; Wang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):569-72. PubMed ID: 25059370
[TBL] [Abstract][Full Text] [Related]
28. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
[TBL] [Abstract][Full Text] [Related]
29. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma.
Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH
Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066
[TBL] [Abstract][Full Text] [Related]
30. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
31. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
Askari MD; Vo-Dinh T
Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
33. FHIT promotes the apoptosis of QBC939 by reducing the expression of cyclin D1.
Huang Q; Xie F; Tang Z; Liu C; Wang C; Hu Y; Qiu L; Wang S; You H; Zhu K; Xu P
Hepatogastroenterology; 2011; 58(107-108):713-8. PubMed ID: 21830375
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
[TBL] [Abstract][Full Text] [Related]
36. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
37. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
38. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression.
Rishi L; Gahlot S; Kathania M; Majumdar S
Biochem Pharmacol; 2009 Jan; 77(1):30-45. PubMed ID: 18851957
[TBL] [Abstract][Full Text] [Related]
39. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis.
Wu Y; Meng L; Wang H; Xu Q; Wang S; Wu S; Xi L; Zhao Y; Zhou J; Xu G; Lu Y; Ma D
Oncol Rep; 2006 Sep; 16(3):625-9. PubMed ID: 16865265
[TBL] [Abstract][Full Text] [Related]
40. [Construction of a gastric cancer related gene GCRG213-specific siRNA expression vector and its effect on gastric cancer cells in vitro].
Gao LL; Wu BY; Wang MW; Zhan DW; Zhang L; You WD; Wang WH
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):84-8. PubMed ID: 17645837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
